Compare LGN & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LGN | NVST |
|---|---|---|
| Founded | 1963 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 4.1B |
| IPO Year | N/A | 2019 |
| Metric | LGN | NVST |
|---|---|---|
| Price | $87.08 | $25.92 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 13 |
| Target Price | ★ $59.50 | $26.46 |
| AVG Volume (30 Days) | ★ 2.1M | 2.1M |
| Earning Date | 05-15-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 104.31 |
| EPS | N/A | ★ 0.28 |
| Revenue | N/A | ★ $2,566,500,000.00 |
| Revenue This Year | $53.66 | $6.67 |
| Revenue Next Year | $11.99 | $3.55 |
| P/E Ratio | ★ N/A | $92.41 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.31 | $16.29 |
| 52 Week High | $82.74 | $30.42 |
| Indicator | LGN | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 81.27 | 43.80 |
| Support Level | $42.97 | $24.21 |
| Resistance Level | N/A | $26.63 |
| Average True Range (ATR) | 3.70 | 0.83 |
| MACD | 1.03 | -0.13 |
| Stochastic Oscillator | 99.12 | 12.50 |
Legence Corp is a provider of engineering, installation and maintenance services for mission-critical systems in buildings. It focuses on high-growth sectors that have technically demanding buildings, including technology, life sciences, healthcare and education. The company specializes in designing, fabricating and installing complex HVAC, process piping and other mechanical, electrical and plumbing (MEP) systems for new facilities and upgrading HVAC, lighting and building controls in existing facilities to make them more energy efficient and sustainable.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.